Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 8,300 shares at $537.04 ($4.5M) on 2026-06-18, disclosed to the SEC on 2026-06-18.
Scheduled sale ($4.5M) by EVP & GENERAL COUNSEL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $537.04 | 1,715 | $921K | 20.5% |
| 2 | $538.03 | 958 | $515K | 11.5% |
| 3 | $539.42 | 1,305 | $704K | 15.7% |
| 4 | $540.25 | 798 | $431K | 9.6% |
| 5 | $541.25 | 950 | $514K | 11.4% |
| 6 | $541.95 | 160 |
| $87K |
| 1.9% |
| 7 | $544.26 | 480 | $261K | 5.8% |
| 8 | $546.15 | 157 | $86K | 1.9% |
| 9 | $547.65 | 881 | $482K | 10.7% |
| 10 | $548.91 | 496 | $272K | 6.1% |
| 11 | $551.74 | 400 | $221K | 4.9% |
| Total | $541.55 avg | 8,300 | $4.5M | 100% |
| Filing → |
| UTHR | SELL | 2026-09-03 | $4.0M | — | Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-08-06 | $4.3M | — | Filing → |